Control of IGFBP-2 expression by steroids and peptide hormones in vertebrates

Frontiers in Endocrinology

Volumn 5, Issue APR, 2014, Pages

  Hoeflich, Andreas ^a   Wirthgen, Elisa ^b   David, Robert ^c   Classen, Carl Friedrich ^d   Spitschak, Marion ^a   Brenmoehl, Julia ^a  

^a LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

^b Ligandis GbR   (Germany)

^c Reference and Translation Center for Cardiac Stem Cell Therapy   (Germany)

^d ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Estradiol; IGFBP 2; Peptide hormones; Steroids; Vertebrates

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; GROWTH HORMONE; INSULIN; NEUROGENIC DIFFERENTIATION FACTOR; PEPTIDE HORMONE; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; SOMATOMEDIN C RECEPTOR; STEROID; UNCLASSIFIED DRUG;

BREAST CANCER; CARCINOGENICITY; DIET; GENE EXPRESSION; GLIOBLASTOMA; GRANULOSA CELL; HUMAN; LIVER CELL; NONHUMAN; PROSTATE EPITHELIUM; REVIEW; SIGNAL TRANSDUCTION;

EID: 84901011383     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00043     Document Type: Review

References (148)

1. Binkert C, Landwehr J, Mary JL, Schwander J, Heinrich G. Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2). EMBO J (1989) 8:2497-502.
2. Zhang W, Fuller G. IGFBP2 as a brain tumor oncogene. Cancer Biol Ther (2007) 6:995-6.
3. Chi F, Wu R, Zeng YC, Xing R, Liu Y. Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysis. Mol Biol Rep (2013) 40:3583-90. doi: 10.1007/s11033-012-2432-z.
4. Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM. Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer (2009) 124:2416-29. doi:10.1002/ijc.24202.
5. Fukushima T, Kataoka H. Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma. Anticancer Res (2007) 27:3685-92.
6. Fottner C, Hoeflich A, Wolf E, Weber MM. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis. Horm Metab Res (2004) 36:397-405. doi:10.1055/s-2004-814563.
7. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev (2002) 23:824-54. doi:10.1210/er.2001-0033.
8. Hoeflich A, Reisinger R, Lahm H, Kiess W, Blum WF, Kolb HJ, et al. Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter? Cancer Res (2001) 61:8601-10.
9. Dunlap SM, Celestino J, Wang H, Jiang R, Holland EC, Fuller GN, et al. Insulin-like growth factor binding protein 2 promotes glioma development and progression. Proc Natl Acad Sci U S A (2007) 104:11736-41. doi:10.1073/pnas.0703145104.
10. Diehl D, Hessel E, Oesterle D, Renner-Müller I, Elmlinger M, Langhammer M, et al. IGFBP-2 overexpression reduces the appearance of dysplastic aberrant crypt foci and inhibits growth of adenomas in chemically induced colorectal carcinogenesis. Int J Cancer (2009) 124:2220-5. doi:10.1002/ijc.24193.
11. Ricciarelli E, Hernandez ER, Hurwitz A, Kokia E, Rosenfeld RG, Schwander J, et al. The ovarian expression of the antigonadotropic insulin-like growth factor binding protein-2 is theca-interstitial cell-selective: evidence for hormonal regulation. Endocrinology (1991) 129:2266-8. doi:10.1210/endo-129-4-2266.
12. Giudice LC, Milkowski DA, Lamson G, Rosenfeld RG, Irwin JC. Insulin-like growth factor binding proteins in human endometrium: steroid-dependent messenger ribonucleic acid expression and protein synthesis. J Clin Endocrinol Metab (1991) 72:779-87. doi:10.1210/jcem-72-4-779.
13. Foulstone EJ, Zeng L, Perks CM, Holly JM. Insulin-like growth factor binding protein 2 (IGFBP-2) promotes growth and survival of breast epithelial cells: novel regulation of the estrogen receptor. Endocrinology (2013) 154:1780-93. doi:10.1210/en.2012-1970.
14. Kita K, Nagao K, Taneda N, Inagaki Y, Hirano K, Shibata T, et al. Insulin-like growth factor binding protein-2 gene expression can be regulated by diet manipulation in several tissues of young chickens. J Nutr (2002) 132:145-51.
15. Bradshaw SL, Han VK. Hormonal regulation of astroglial insulin-like growth factor (IGF)-binding protein gene expression by IGFs and insulin. Endocrinology (1993) 133:1767-77. doi:10.1210/endo.133.4.7691580.
16. Sárvári M, Kalló I, Hrabovszky E, Solymosi N, Tóth K, Likó I, et al. Estradiol replacement alters expression of genes related to neurotransmission and immune surveillance in the frontal cortex of middle-aged, ovariectomized rats. Endocrinology (2010) 151:3847-62. doi:10.1210/en.2010-0375.
17. Bezchlibnyk YB, Wang JF, Shao L, Young LT. Insulin-like growth factor binding protein-2 expression is decreased by lithium. Neuroreport (2006) 17:897-901. doi:10.1097/01.wnr.0000220143.37036.32.
18. Takeo C, Ikeda K, Horie-Inoue K, Inoue S. Identification of Igf2, Igfbp2 and Enpp2 as estrogen-responsive genes in rat hippocampus. Endocr J (2009) 56:113-20. doi:10.1507/endocrj. K08E-220.
19. Pechenino AS, Frick KM. The effects of acute 17beta-estradiol treatment on gene expression in the young female mouse hippocampus. Neurobiol Learn Mem (2009) 91:315-22. doi:10.1016/j.nlm.2008.09.017.
20. Erabi K, Morinobu S, Kawano K, Tsuji S, Yamawaki S. Neonatal isolation changes the expression of IGF-IR and IGFBP-2 in the hippocampus in response to adulthood restraint stress. Int J Neuropsychopharmacol (2007) 10:369-81. doi:10.1017/S1461145706006675.
21. Pons S, Torres-Aleman I. Estradiol modulates insulin-like growth factor I receptors and binding proteins in neurons from the hypothalamus. J Neuroendocrinol (1993) 5:267-71. doi:10.1111/j.1365-2826.1993.tb00482.x.
22. Cardona-Gomez GP, Chowen JA, Garcia-Segura LM. Estradiol and progesterone regulate the expression of insulin-like growth factor-I receptor and insulin-like growth factor binding protein-2 in the hypothalamus of adult female rats. J Neurobiol (2000) 43:269-81. doi:10.1002/(SICI)1097-4695(20000605)43:3<269::AID-NEU5>3.0.CO;2-D.
23. Clapper JA, Snyder JL, Roberts AJ, Hamernik DL, Moss GE. Estradiol increases relative amounts of insulin-like growth factor binding protein (IGFBP)-3 in serum and expression of IGFBP-2 in anterior pituitaries of ewes. Biol Reprod (1998) 59:124-30. doi:10.1095/biolreprod59.1.124.
24. Rempel LA, Clapper JA. Administration of estradiol-17beta increases anterior pituitary IGF-I and relative amounts of serum and anterior pituitary IGF-binding proteins in barrows. J Anim Sci (2002) 80:214-24.
25. Michels KM, Lee WH, Seltzer A, Saavedra JM, Bondy CA. Up-regulation of pituitary [125I]insulin-like growth factor-I (IGF-I) binding and IGF binding protein-2 and IGF-I gene expression by estrogen. Endocrinology (1993) 132:23-9. doi:10.1210/en.132.1.23.
26. Min SH, Simmen RC, Alhonen L, Halmekyto M, Porter CW, Janne J, et al. Altered levels of growth-related and novel gene transcripts in reproductive and other tissues of female mice overexpressing spermidine/spermine N1-acetyltransferase (SSAT). J Biol Chem (2002) 277:3647-57. doi:10.1074/jbc. M100751200.
27. Echternkamp SE, Howard HJ, Roberts AJ, Grizzle J, Wise T. Relationships among concentrations of steroids, insulin-like growth factor-I, and insulin-like growth factor binding proteins in ovarian follicular fluid of beef cattle. Biol Reprod (1994) 51:971-81. doi:10.1095/biolreprod51.5.971.
28. Ginther OJ, Bergfelt DR, Beg MA, Kot K. Effect of LH on circulating oestradiol and follicular fluid factor concentrations during follicle deviation in cattle. Reproduction (2001) 122:103-10. doi:10.1530/rep.0.1220103.
29. Stanko RL, Cohick WS, Shaw DW, Harvey RW, Clemmons DR, Whitacre MD, et al. Effect of somatotropin and/or equine chorionic gonadotropin on serum and follicular insulin-like growth factor I and insulin-like growth factor binding proteins in cattle. Biol Reprod (1994) 50:290-300. doi:10.1095/biolreprod50.2.290.
30. Davidson TR, Chamberlain CS, Bridges TS, Spicer LJ. Effect of follicle size on in vitro production of steroids and insulin-like growth factor (IGF)-I, IGF-II, and the IGF-binding proteins by equine ovarian granulosa cells. Biol Reprod (2002) 66:1640-8. doi:10.1095/biolreprod66.6.1640.
31. Muñoz-Gutiérrez M, Findlay PA, Adam CL, Wax G, Campbell BK, Kendall NR, et al. The ovarian expression of mRNAs for aromatase, IGF-I receptor, IGF-binding protein-2,-4 and-5, leptin and leptin receptor in cycling ewes after three days of leptin infusion. Reproduction (2005) 130:869-81. doi:10.1530/rep.1.00557.
32. Kamangar BB, Gabillard JC, Bobe J. Insulin-like growth factor-binding protein (IGFBP)-1,-2,-3,-4,-5, and-6 and IGFBP-related protein 1 during rainbow trout postvitellogenesis and oocyte maturation: molecular characterization, expression profiles, and hormonal regulation. Endocrinology (2006) 147:2399-410. doi:10.1210/en.2005-1570.
33. Cataldo NA, Fujimoto VY, Jaffe RB. Interferon-gamma and activin A promote insulin-like growth factor-binding protein-2 and-4 accumulation by human luteinizing granulosa cells, and interferon-gamma promotes their apoptosis. J Clin Endocrinol Metab (1998) 83:179-86. doi:10.1210/jcem.83.1.4481.
34. Greisen S, Flyvbjerg A, Ledet T, Ovesen P. Regulation of insulin-like growth factor binding protein secretion by human granulosa luteal cells in a polycystic ovary-like environment. Fertil Steril (2002) 78:162-8. doi:10.1016/S0015-0282(02)03147-3.
35. Walters KA, Binnie JP, Campbell BK, Armstrong DG, Telfer EE. The effects of IGF-I on bovine follicle development and IGFBP-2 expression are dose and stage dependent. Reproduction (2006) 131:515-23. doi:10.1530/rep.1.00682.
36. Chen W, Wang Y, Li W, Lin H. Insulin-like growth factor binding protein-2 (IGFBP-2) in orange-spotted grouper, Epinephelus coioides: molecular characterization, expression profiles and regulation by 17beta-estradiol in ovary. Comp Biochem Physiol B Biochem Mol Biol (2010) 157:336-42. doi:10.1016/j.cbpb.2010.08.001.
37. Simmen RC, Simmen FA, Hofig A, Farmer SJ, Bazer FW. Hormonal regulation of insulin-like growth factor gene expression in pig uterus. Endocrinology (1990) 127:2166-74. doi:10.1210/endo-127-5-2166.
38. Ohleth KM, Lenhart JA, Ryan PL, Radecki SV, Bagnell CA. Relaxin increases insulin-like growth factors (IGFs) and IGF-binding proteins of the pig uterus in vivo. Endocrinology (1997) 138:3652-8. doi:10.1210/en.138.9.3652.
39. Wu X, Pang ST, Sahlin L, Blanck A, Norstedt G, Flores-Morales A. Gene expression profiling of the effects of castration and estrogen treatment in the rat uterus. Biol Reprod (2003) 69:1308-17. doi:10.1095/biolreprod.103.015420.
40. Giudice LC, Milkowski DA, Fielder PJ, Irwin JC. Characterization of the steroid-dependence of insulin-like growth factor-binding protein-2 synthesis and mRNA expression in cultured human endometrial stromal cells. Hum Reprod (1991) 6:632-40.
41. Fleming SD, Fazleabas AT, Bell SC. Differential regulation of insulin-like growth factor binding protein-1 and-2 by insulin in the baboon (Papio anubis) endometrium. Reprod Biol Endocrinol (2008) 6:6. doi:10.1186/1477-7827-6-6.
42. Adesanya OO, Zhou J, Bondy CA. Cellular localization and sex steroid regulation of insulin-like growth factor binding protein messenger ribonucleic acids in the primate myometrium. J Clin Endocrinol Metab (1996) 81:2495-501. doi:10.1210/jc.81.7.2495.
43. Suzuki A, Urushitani H, Watanabe H, Sato T, Iguchi T, Kobayashi T, et al. Comparison of estrogen responsive genes in the mouse uterus, vagina and mammary gland. J Vet Med Sci (2007) 69:725-31. doi:10.1292/jvms.69.725.
44. Mireuta M, Darnel A, Pollak M. IGFBP-2 expression in MCF-7 cells is regulated by the PI3K/AKT/mTOR pathway through Sp1-induced increase in transcription. Growth Factors (2010) 28:243-55. doi:10.3109/08977191003745472.
45. Chan TW, Pollak M, Huynh H. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780. Clin Cancer Res (2001) 7:2545-54.
46. Sheikh MS, Shao ZM, Hussain A, Clemmons DR, Chen JC, Roberts CT Jr, et al. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells. J Cell Physiol (1993) 155:556-67. doi:10.1002/jcp.1041550314.
47. Martin JL, Baxter RC. Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. Endocrinology (2007) 148:2532-41. doi:10.1210/en.2006-1335.
48. Milewicz T, Gregoraszczuk EL, Sztefko K, Augustowska K, Krzysiek J, Rys J. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486). Growth Horm IGF Res (2005) 15:140-7. doi:10.1016/j.ghir.2004.12.006.
49. Dubois V, Couissi D, Schonne E, Remacle C, Trouet A. Intracellular levels and secretion of insulin-like-growth-factor-binding proteins in MCF-7/6, MCF-7/AZ and MDA-MB-231 breast cancer cells. Differential modulation by estrogens in serum-free medium. Eur J Biochem (1995) 232:47-53. doi:10.1111/j.1432-1033.1995.tb20779.x.
50. Fog CK, Christensen IJ, Lykkesfeldt AE. Characterization of a human breast cancer cell line, MCF-7/RU58R-1, resistant to the pure antiestrogen RU 58,668. Breast Cancer Res Treat (2005) 91:133-44. doi:10.1007/s10549-004-5871-y.
51. Korc-Grodzicki B, Ren N, Hilf R. Effects of estradiol on the expression and production of IGFBP-2 by R3230AC mammary tumor cells. Oncol Res (1996) 8:473-83.
52. Thomas LN, Wright AS, Lazier CB, Cohen P, Rittmaster RS. Prostatic involution in men taking finasteride is associated with elevated levels of insulin-like growth factor-binding proteins (IGFBPs)-2,-4, and-5. Prostate (2000) 42:203-10. doi:10.1002/(SICI)1097-0045(20000215)42:3<203::AID-PROS6>3.0.CO;2-Y.
53. Nickerson T, Pollak M. Bicalutamide (Casodex)-induced prostate regression involves increased expression of genes encoding insulin-like growth factor binding proteins. Urology (1999) 54:1120-5. doi:10.1016/S0090-4295(99)00421-5.
54. Le H, Arnold JT, McFann KK, Blackman MR. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells. Am J Physiol Endocrinol Metab (2006) 290:E952-60. doi:10.1152/ajpendo.00451.2005.
55. Martin JL, Pattison SL. Insulin-like growth factor binding protein-3 is regulated by dihydrotestosterone and stimulates deoxyribonucleic acid synthesis and cell proliferation in LNCaP prostate carcinoma cells. Endocrinology (2000) 141:2401-9. doi:10.1210/endo.141.7.7534.
56. Arnold JT, Le H, McFann KK, Blackman MR. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Am J Physiol Endocrinol Metab (2005) 288:E573-84. doi:10.1152/ajpendo.00454.2004.
57. DegraffDJ, Aguiar AA, Chen Q, Adams LK, Williams BJ, Sikes RA. Androgen mediated translational and posttranslational regulation of IGFBP-2 in androgen-sensitive LNCaP human prostate cancer cells. Am J Transl Res (2010) 2:200-8.
58. Kiyama S, Morrison K, Zellweger T, Akbari M, Cox M, Yu D, et al. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors. Cancer Res (2003) 63:3575-84.
59. DegraffDJ, Malik M, Chen Q, Miyako K, Rejto L, Aguiar AA, et al. Hormonal regulation of IGFBP-2 proteolysis is attenuated with progression to androgen insensitivity in the LNCaP progression model. J Cell Physiol (2007) 213:261-8. doi:10.1002/jcp.21123.
60. Stewart LV, Weigel NL. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells. Prostate (2005) 64:9-19. doi:10.1002/pros.20212.
61. Wang D, Nagpal ML, Lin T, Shimasaki S, Ling N. Insulin-like growth factor-binding protein-2: the effect of human chorionic gonadotropin on its gene regulation and protein secretion and its biological effects in rat Leydig cells. Mol Endocrinol (1994) 8:69-76. doi:10.1210/mend.8.1.7512196.
62. Hedbacker K, Birsoy K, Wysocki RW, Asilmaz E, Ahima RS, Farooqi IS, et al. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab (2010) 11:11-22. doi:10.1016/j.cmet.2009.11.007.
63. Ooi GT, Orlowski CC, Brown AL, Becker RE, Unterman TG, Rechler MM. Different tissue distribution and hormonal regulation of messenger RNAs encoding rat insulin-like growth factor-binding proteins-1 and-2. Mol Endocrinol (1990) 4:321-8. doi:10.1210/mend-4-2-321.
64. Straus DS, Takemoto CD. Effect of dietary protein deprivation on insulin-like growth factor (IGF)-I and-II, IGF binding protein-2, and serum albumin gene expression in rat. Endocrinology (1990) 127:1849-60. doi:10.1210/endo-127-4-1849.
65. Tseng LY, Ooi GT, Brown AL, Straus DS, Rechler MM. Transcription of the insulin-like growth factor-binding protein-2 gene is increased in neonatal and fasted adult rat liver. Mol Endocrinol (1992) 6:1195-201. doi:10.1210/mend.6.8.1383692.
66. Boni-Schnetzler M, Binz K, Mary JL, Schmid C, Schwander J, Froesch ER. Regulation of hepatic expression of IGF I and fetal IGF binding protein mRNA in streptozotocin-diabetic rats. FEBS Lett (1989) 251:253-6. doi:10.1016/0014-5793(89)81465-6.
67. Nagao K, Aman Yaman M, Murai A, Sasaki T, Saito N, Okumura J, et al. Insulin administration suppresses an increase in insulin-like growth factor binding protein-2 gene expression stimulated by fasting in the chicken. Br Poult Sci (2001) 42:501-4. doi:10.1080/00071660120070622.
68. Schmid C, Schläpfer I, Waldvogel M, Meier PJ, Schwander J, Böni-Schnetzler M, et al. Differential regulation of insulin-like growth factor binding protein (IGFBP)-2 mRNA in liver and bone cells by insulin and retinoic acid in vitro. FEBS Lett (1992) 303:205-9. doi:10.1016/0014-5793(92)80520-Q.
69. Böni-Schnetzler M, Schmid C, Mary JL, Zimmerli B, Meier PJ, Zapf J, et al. Insulin regulates the expression of the insulin-like growth factor binding protein 2 mRNA in rat hepatocytes. Mol Endocrinol (1990) 4:1320-6. doi:10.1210/mend-4-9-1320.
70. Crespi EJ, Steckler TL, Mohankumar PS, Padmanabhan V. Prenatal exposure to excess testosterone modifies the developmental trajectory of the insulin-like growth factor system in female sheep. J Physiol (2006) 572:119-30.
71. Reijnders CM, Bravenboer N, Holzmann PJ, Bhoelan F, Blankenstein MA, Lips P. In vivo mechanical loading modulates insulin-like growth factor binding protein-2 gene expression in rat osteocytes. Calcif Tissue Int (2007) 80:137-43. doi:10.1007/s00223-006-0077-4.
72. Boisclair YR, Yang YW, Stewart JM, Rechler MM. Insulin-like growth factor-I and insulin stimulate the synthesis of IGF-binding protein-2 in a human embryonic kidney cell line. Growth Regul (1994) 4:136-46.
73. Cazals V, Nabeyrat E, Corroyer S, de Keyzer Y, Clement A. Role for NF-kappa B in mediating the effects of hyperoxia on IGF-binding protein 2 promoter activity in lung alveolar epithelial cells. Biochim Biophys Acta (1999) 1448:349-62. doi:10.1016/S0167-4889(98)00095-0.
74. Cazals V, Mouhieddine B, Maitre B, Le Bouc Y, Chadelat K, Brody JS, et al. Insulin-like growth factors, their binding proteins, and transforming growth factor-beta 1 in oxidant-arrested lung alveolar epithelial cells. J Biol Chem (1994) 269:14111-7.
75. Chetty A, Manzo N, Waxman AB, Nielsen HC. Modulation of IGF-binding protein-2 and-3 in hyperoxic injury in developing rat lung. Pediatr Res (2005) 58:222-8. doi:10.1203/01.PDR.0000169973.42653.68.
76. Liu HC, Chang LW, Rong ZH, Zhu HP, Zhang QS, Chen HB, et al. [Relation of insulin-like growth factor binding protein-2 with hyperoxia-induced lung injury in term and premature neonatal rats]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue (2008) 20:331-4. doi:10.3736/jcim20080401.
77. Yazawa T, Sato H, Shimoyamada H, Okudela K, Woo T, Tajiri M, et al. Neuroendocrine cancer-specific up-regulating mechanism of insulin-like growth factor binding protein-2 in small cell lung cancer. Am J Pathol (2009) 175:976-87. doi:10.2353/ajpath.2009.081004.
78. Bostedt KT, Schmid C, Ghirlanda-Keller C, Olie R, Winterhalter KH, Zapf J. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells. Exp Cell Res (2001) 271:368-77. doi:10.1006/excr.2001.5388.
79. Yakar S, Domene H, Meidan R, Cassorla F, Gilad I, Koch I, et al. Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-binding protein (IGFBP)-2 gene expression in spleens of juvenile rats. Horm Metab Res (1994) 26:363-6. doi:10.1055/s-2007-1001707.
80. Oh YS, Kim EJ, Schaffer BS, Kang YH, Binderup L, MacDonald RG, et al. Synthetic low-calcaemic vitamin D(3) analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells. Mol Cell Endocrinol (2001) 183:141-9. doi:10.1016/S0303-7207(01)00598-6.
81. Averbukh E, Weiss O, Halpert M, Yanko R, Moshe R, Nephesh I, et al. Gene expression of insulin-like growth factor-I, its receptor and binding proteins in retina under hypoxic conditions. Metabolism (1998) 47:1331-6. doi:10.1016/S0026-0495(98)90300-6.
82. Nachtrab G, Czerwinski M, Poss KD. Sexually dimorphic fin regeneration in zebrafish controlled by androgen/GSK3 signaling. Curr Biol (2011) 21:1912-7. doi:10.1016/j.cub.2011.09.050.
83. Ernst CW, White ME. Hormonal regulation of IGF-binding protein-2 expression in proliferating C2C12 myoblasts. J Endocrinol (1996) 149:417-29. doi:10.1677/joe.0.1490417.
84. Diesing D, Elmlinger MW, Schuett BS, Weidemann W, Romalo G, Schweikert HU, et al. Genital skin fibroblasts (GF) of patients with androgen insensitivity syndrome express higher insulin-like growth factor binding protein (IGFBP)-2,-3 and-5 than GF of normally virilized males. Horm Res (2003) 60:73-8. doi:10.1159/000071874.
85. Kutoh E, Margot JB, Schwander J. Genomic structure and regulation of the promoter of the rat insulin-like growth factor binding protein-2 gene. Mol Endocrinol (1993) 7:1205-16. doi:10.1210/mend.7.9.7504179.
86. Brown AL, Rechler MM. Cloning of the rat insulin-like growth factor-binding protein-2 gene and identification of a functional promoter lacking a TATA box. Mol Endocrinol (1990) 4:2039-51. doi:10.1210/mend-4-12-2039.
87. Boisclair YR, Brown AL, Casola S, Rechler MM. Three clustered Sp1 sites are required for efficient transcription of the TATA-less promoter of the gene for insulin-like growth factor-binding protein-2 from the rat. J Biol Chem (1993) 268:24892-901.
88. Song S, Lee CY, Green ML, Chung CS, Simmen RC, Simmen FA. The unique endometrial expression and genomic organization of the porcine IGFBP-2 gene. Mol Cell Endocrinol (1996) 120:193-202. doi:10.1016/0303-7207(96)03837-3.
89. Kwak I, Song S, Blum JL, Simmen RC, Simmen FA. Enhancer-and silencer-like sequences that mediate insulin-like growth factor-binding protein-2 gene expression in uterine cells of pregnancy. DNA Cell Biol (2006) 25:6-18. doi:10.1089/dna.2006.25.6.
90. Badinga L, Song S, Simmen RC, Simmen FA. A distal regulatory region of the insulin-like growth factor binding protein-2 (IGFBP-2) gene interacts with the basic helix-loop-helix transcription factor, AP-4. Endocrine (1998) 8:281-9. doi:10.1385/ENDO:8:3:281.
91. Cindolo L, Franco R, Cantile M, Schiavo G, Liguori G, Chiodini P, et al. NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension? Eur Urol (2007) 52:1365-73. doi:10.1016/j.eururo.2006.11.030.
92. Hilleson-Gayne CK, Clapper JA. Effects of decreased estradiol-17beta on the serum and anterior pituitary IGF-I system in pigs. J Endocrinol (2005) 187:369-78. doi:10.1677/joe.1.06253.
93. Ribeiro MF, Garcia-Segura LM. Dehydroepiandrosterone regulates insulin-like growth factor-1 system in adult rat hypothalamus. Endocrine (2002) 17:129-34. doi:10.1385/ENDO:17:2:129.
94. Fuller GN, Rhee CH, Hess KR, Caskey LS, Wang R, Bruner JM, et al. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res (1999) 59:4228-32.
95. Mehrian-Shai R, Chen CD, Shi T, Horvath S, Nelson SF, Reichardt JK, et al. Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer. Proc Natl Acad Sci U S A (2007) 104:5563-8. doi:10.1073/pnas.0609139104.
96. Ahani N, Karimi AM, Shirkoohi R, Rokouei M, Alipour EM, Nikravesh A. Expression of insulin-like growth factor binding protein-2 (IGFBP-2) gene in negative and positive human cytomegalovirus glioblastoma multiforme tissues. Med Oncol (2014) 31:812. doi:10.1007/s12032-013-0812-4.
97. Fukushima T, Tezuka T, Shimomura T, Nakano S, Kataoka H. Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24. J Biol Chem (2007) 282:18634-44. doi:10.1074/jbc. M609567200.
98. Moore LM, Holmes KM, Smith SM, Wu Y, Tchougounova E, Uhrbom L, et al. IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas. Proc Natl Acad Sci U S A (2009) 106:16675-9. doi:10.1073/pnas.0900807106.
99. Altiok N, Ersoz M, Koyuturk M. Estradiol induces JNK-dependent apoptosis in glioblastoma cells. Oncol Lett (2011) 2:1281-5.
100. DeMambro VE, Maile L, Wai C, Kawai M, Cascella T, Rosen CJ, et al. Insulin-like growth factor-binding protein-2 is required for osteoclast differentiation. J Bone Miner Res (2012) 27:390-400. doi:10.1002/jbmr.545.
101. Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, et al. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk. Gynecol Endocrinol (2005) 20:176-82. doi:10.1080/09513590400027406.
102. Rooman RP, De Beeck LO, Martin M, van Doorn J, Mohan S, Du Caju MV. Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature. Eur J Endocrinol (2005) 152:597-604. doi:10.1530/eje.1.01880.
103. Münzer T, Rosen CJ, Harman SM, Pabst KM, St Clair C, Sorkin JD, et al. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men. Am J Physiol Endocrinol Metab (2006) 290:E1006-13. doi:10.1152/ajpendo.00166.2005.
104. Howard HJ, Ford JJ. Relationships among concentrations of steroids, inhibin, insulin-like growth factor-1 (IGF-1), and IGF-binding proteins during follicular development in weaned sows. Biol Reprod (1992) 47:193-201. doi:10.1095/biolreprod47.2.193.
105. Walters KA, Armstrong DG, Telfer EE. Bovine mural granulosa cells, and not the oocyte, are the major source of proteases capable of IGFBP-2 degradation. Anim Reprod Sci (2007) 98:365-70. doi:10.1016/j.anireprosci.2006.04.047.
106. Simmen FA, Simmen RC, Geisert RD, Martinat-Botte F, Bazer FW, Terqui M. Differential expression, during the estrous cycle and pre-and post-implantation conceptus development, of messenger ribonucleic acids encoding components of the pig uterine insulin-like growth factor system. Endocrinology (1992) 130:1547-56. doi:10.1210/en.130.3.1547.
107. Geisert RD, Chamberlain CS, Vonnahme KA, Malayer JR, Spicer LJ. Possible role of kallikrein in proteolysis of insulin-like growth factor binding proteins during the oestrous cycle and early pregnancy in pigs. Reproduction (2001) 121:719-28. doi:10.1530/rep.0.1210719.
108. Elmlinger MW, Grund R, Buck M, Wollmann HA, Feist N, Weber MM, et al. Limited proteolysis of the IGF binding protein-2 (IGFBP-2) by a specific serine protease activity in early breast milk. Pediatr Res (1999) 46:76-81. doi:10.1203/00006450-199907000-00013.
109. Lee CY, Bazer FW, Simmen FA. Expression of components of the insulin-like growth factor system in pig mammary glands and serum during pregnancy and pseudopregnancy: effects of oestrogen. J Endocrinol (1993) 137:473-83. doi:10.1677/joe.0.1370473.
110. Maxwell P, van den Berg HW. Changes in the secretion of insulin-like growth factor binding proteins-2 and-4 associated with the development of tamoxifen resistance and estrogen independence in human breast cancer cell lines. Cancer Lett (1999) 139:121-7. doi:10.1016/S0304-3835(99)00009-9.
111. Juncker-Jensen A, Lykkesfeldt AE, Worm J, Ralfkiaer U, Espelund U, Jepsen JS. Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator. Growth Horm IGF Res (2006) 16:224-39. doi:10.1016/j.ghir.2006.06.005.
112. Yee D, Lee AV. Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mammary Gland Biol Neoplasia (2000) 5:107-15. doi:10.1023/A:1009575518338.
113. Eder IE, Haag P, Basik M, Mousses S, Bektic J, Bartsch G, et al. Gene expression changes following androgen receptor elimination in LNCaP prostate cancer cells. Mol Carcinog (2003) 37:181-91. doi:10.1002/mc.10136.
114. Nickerson T, Pollak M, Huynh H. Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2,3,4 and 5. Endocrinology (1998) 139:807-10. doi:10.1210/endo.139.2.5912.
115. Zapf J, Schmid C, Guler HP, Waldvogel M, Hauri C, Futo E, et al. Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. J Clin Invest (1990) 86:952-61. doi:10.1172/JCI114797.
116. Blum WF, Horn N, Kratzsch J, Jørgensen JO, Juul A, Teale D, et al. Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regul (1993) 3:100-4.
117. Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment. Clin Endocrinol (Oxf) (2006) 65:310-9. doi:10.1111/j.1365-2265.2006.02594.x.
118. Katz LE, Liu F, Baker B, Agus MS, Nunn SE, Hintz RL, et al. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab (1996) 81:1141-6. doi:10.1210/jcem.81.3.8772589.
119. Kassem M, Brixen K, Mosekilde L, Blum WF, Flyvbjerg A. Effects of growth hormone treatment on serum levels of insulin-like growth factors (IGFs) and IGF binding proteins 1-4 in postmenopausal women. Clin Endocrinol (Oxf) (1998) 49:747-56. doi:10.1046/j.1365-2265.1998.00606.x.
120. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, Kopchick JJ. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology (2003) 144:3799-810. doi:10.1210/en.2003-0374.
121. Young SC, Underwood LE, Celniker A, Clemmons DR. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults. J Clin Endocrinol Metab (1992) 75:603-8. doi:10.1210/jc.75.2.603.
122. Lee PD, Durham SK, Martinez V, Vasconez O, Powell DR, Guevara-Aguirre J. Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses to a single dose of growth hormone. J Clin Endocrinol Metab (1997) 82:2266-74. doi:10.1210/jcem.82.7.4048.
123. Kicman AT, Miell JP, Teale JD, Powrie J, Wood PJ, Laidler P, et al. Serum IGF-I and IGF binding proteins 2 and 3 as potential markers of doping with human GH. Clin Endocrinol (Oxf) (1997) 47:43-50. doi:10.1046/j.1365-2265.1997.2111036.x.
124. Guha N, Erotokritou-Mulligan I, Nevitt SP, Francis M, Bartlett C, Cowan DA, et al. Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes. Drug Test Anal (2013) 5(11-12):843-9. doi:10.1002/dta.1562.
125. Donahue LR, Watson G, Beamer WG. Regulation of metabolic water and protein compartments by insulin-like growth factor-I and testosterone in growth hormone-deficient lit/lit mice. J Endocrinol (1993) 139:431-9. doi:10.1677/joe.0.1390431.
126. McCann JP, Loo SC, Aalseth DL, Abribat T. Differential effects of GH stimulation on fasting and prandial metabolism and plasma IGFs and IGF-binding proteins in lean and obese sheep. J Endocrinol (1997) 154:329-46. doi:10.1677/joe.0.1540329.
127. Thrailkill K, Quattrin T, Baker L, Litton J, Dwigun K, Rearson M, et al. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system. J Clin Endocrinol Metab (1997) 82:1181-7. doi:10.1210/jc.82.4.1181.
128. Wolf E, Jehle PM, Weber MM, Sauerwein H, Daxenberger A, Breier BH, et al. Human insulin-like growth factor I (IGF-I) produced in the mammary glands of transgenic rabbits: yield, receptor binding, mitogenic activity, and effects on IGF-binding proteins. Endocrinology (1997) 138:307-13. doi:10.1210/en.138.1.307.
129. Metzger F, Sajid W, Saenger S, Staudenmaier C, van der Poel C, Sobottka B, et al. Separation of fast from slow anabolism by site-specific PEGylation of insulin-like growth factor I (IGF-I). J Biol Chem (2011) 286:19501-10. doi:10.1074/jbc. M110.172189.
130. Wolf E, Kramer R, Blum WF, Foll J, Brem G. Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growth. Endocrinology (1994) 135:1877-86. doi:10.1210/en.135.5.1877.
131. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ, et al. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem (1994) 269:13779-84.
132. Reijnders CM, Koster JG, van Buul-Offers SC. Overexpression of human IGF-II mRNA in the brain of transgenic mice modulates IGFBP-2 gene expression in the medulla oblongata. J Endocrinol (2004) 182:445-55. doi:10.1677/joe.0.1820445.
133. Grinspoon S, Miller K, Herzog D, Clemmons D, Klibanski A. Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled study. J Clin Endocrinol Metab (2003) 88:1142-9. doi:10.1210/jc.2002-021402.
134. Wheatcroft SB, Kearney MT, Shah AM, Ezzat VA, Miell JR, Modo M, et al. IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes (2007) 56:285-94. doi:10.2337/db06-0436.
135. Wheatcroft SB, Kearney MT. IGF-dependent and IGF-independent actions of IGF-binding protein-1 and-2: implications for metabolic homeostasis. Trends Endocrinol Metab (2009) 20:153-62. doi:10.1016/j.tem.2009.01.002.
136. Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, Keinan-Boker L, et al. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1,-2 and-3 in women in the Netherlands. Cancer Causes Control (2004) 15:787-96. doi:10.1023/B:CACO.0000043429.51915.c6.
137. Crowe FL, Key TJ, Allen NE, Appleby PN, Roddam A, Overvad K, et al. The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev (2009) 18:1333-40. doi:10.1158/1055-9965.EPI-08-0781.
138. Pucilowska JB, Davenport ML, Kabir I, Clemmons DR, Thissen JP, Butler T, et al. The effect of dietary protein supplementation on insulin-like growth factors (IGFs) and IGF-binding proteins in children with shigellosis. J Clin Endocrinol Metab (1993) 77:1516-21. doi:10.1210/jc.77.6.1516.
139. Vrieling A, Voskuil DW, Bonfrer JM, Korse CM, van Doorn J, Cats A, et al. Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and-2 concentrations in persons at greater risk of colorectal cancer. Am J Clin Nutr (2007) 86:1456-62.
140. Arafat AM, Weickert MO, Frystyk J, Spranger J, SchöflC, Möhlig M, et al. The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity. J Clin Endocrinol Metab (2009) 94:5093-101. doi:10.1210/jc.2009-0875.
141. McGuire MA, Dwyer DA, Harrell RJ, Bauman DE. Insulin regulates circulating insulin-like growth factors and some of their binding proteins in lactating cows. Am J Physiol (1995) 269:E723-30.
142. Butler ST, Pelton SH, Butler WR. Insulin increases 17 beta-estradiol production by the dominant follicle of the first postpartum follicle wave in dairy cows. Reproduction (2004) 127:537-45. doi:10.1530/rep.1.00079.
143. Counts DR, Gwirtsman H, Carlsson LM, Lesem M, Cutler GB Jr. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab (1992) 75:762-7. doi:10.1210/jcem.75.3.1381372.
144. Morishita D, Sasaki K, Wakita M, Hoshino S. Effect of fasting on serum insulin-like growth factor-I (IGF-I) levels and IGF-I-binding activity in cockerels. J Endocrinol (1993) 139:363-70. doi:10.1677/joe.0.1390363.
145. Straus DS. Nutritional regulation of hormones and growth factors that control mammalian growth. FASEB J (1994) 8:6-12.
146. Maxwell A, Butterwick R, Yateman M, Batt RM, Cotterill A, Camacho-Hubner C. Nutritional modulation of canine insulin-like growth factors and their binding proteins. J Endocrinol (1998) 158:77-85. doi:10.1677/joe.0.1580077.
147. Peterson BC, Waldbieser GC. Effects of fasting on IGF-I, IGF-II, and IGF-binding protein mRNA concentrations in channel catfish (Ictalurus punctatus). Domest Anim Endocrinol (2009) 37:74-83. doi:10.1016/j.domaniend.2009.03.004.
148. Munoz-Gutierrez M, Blache D, Martin GB, Scaramuzzi RJ. Ovarian follicular expression of mRNA encoding the type I IGF receptor and IGF-binding protein-2 in sheep following five days of nutritional supplementation with glucose, glucosamine or lupins. Reproduction (2004) 128:747-56. doi:10.1530/rep.1.00439.